Adakveo is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Adakveo is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameAdakveo
Authorized genericcrizanlizumab
Regular genericcrizanlizumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Adakveo?
The original
–
–

Brand nameThe maker’s card

Novartis Oncology Universal Co-pay Program

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $15,000 a year off your co-pay.

Sign up on us.adakveo.com 

Or call 1-800-282-7630.

In the maker’s words

“Eligible patients with private insurance may pay as little as $0 for your ADAKVEO treatment each month…”

From the maker’s offer on us.adakveo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Adakveo itself, from the same company, sold without the brand name, and usually for less. For now Adakveo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Adakveo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ADAKVEO is a selectin blocker indicated to reduce the frequency of vasoocclusive crises in adults and pediatric patients aged 16 years and older with sickle cell disease.

Source: the FDA label for Adakveo (Novartis Pharmaceuticals Corporation), June 4, 2026. Full label on DailyMed 

Good to know